Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Nature medicine 24 (10), 1550-1558, 2018 | 3653 | 2018 |
An immunogenic personal neoantigen vaccine for patients with melanoma PA Ott, Z Hu, DB Keskin, SA Shukla, J Sun, DJ Bozym, W Zhang, A Luoma, ... Nature 547 (7662), 217-221, 2017 | 2748 | 2017 |
Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein KW Wucherpfennig, JL Strominger Cell 80 (5), 695-705, 1995 | 1990 | 1995 |
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial DB Keskin, AJ Anandappa, J Sun, I Tirosh, ND Mathewson, S Li, ... Nature 565 (7738), 234-239, 2019 | 1240 | 2019 |
A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ... Cell 175 (4), 984-997. e24, 2018 | 1141 | 2018 |
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation T Korn, J Reddy, W Gao, E Bettelli, A Awasthi, TR Petersen, BT Bäckström, ... Nature medicine 13 (4), 423-431, 2007 | 1013 | 2007 |
Radiotherapy induces responses of lung cancer to CTLA-4 blockade SC Formenti, NP Rudqvist, E Golden, B Cooper, E Wennerberg, ... Nature medicine 24 (12), 1845-1851, 2018 | 809 | 2018 |
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing D Pan, A Kobayashi, P Jiang, L Ferrari de Andrade, RE Tay, AM Luoma, ... Science 359 (6377), 770-775, 2018 | 756 | 2018 |
A functional and structural basis for TCR cross-reactivity in multiple sclerosis HLE Lang, H Jacobsen, S Ikemizu, C Andersson, K Harlos, L Madsen, ... Nature immunology 3 (10), 940-943, 2002 | 749 | 2002 |
MHC-II neoantigens shape tumour immunity and response to immunotherapy E Alspach, DM Lussier, AP Miceli, I Kizhvatov, M DuPage, AM Luoma, ... Nature 574 (7780), 696-701, 2019 | 727 | 2019 |
Deconstructing the peptide-MHC specificity of T cell recognition ME Birnbaum, JL Mendoza, DK Sethi, S Dong, J Glanville, J Dobbins, ... Cell 157 (5), 1073-1087, 2014 | 618 | 2014 |
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq MG Filbin, I Tirosh, V Hovestadt, MKL Shaw, LE Escalante, ... Science 360 (6386), 331-335, 2018 | 606 | 2018 |
The organizing principle in the formation of the T cell receptor-CD3 complex ME Call, J Pyrdol, M Wiedmann, KW Wucherpfennig Cell 111 (7), 967-979, 2002 | 593 | 2002 |
Mechanisms for the induction of autoimmunity by infectious agents KW Wucherpfennig The Journal of clinical investigation 108 (8), 1097-1104, 2001 | 590 | 2001 |
Regulation of T cell receptor activation by dynamic membrane binding of the CD3ɛ cytoplasmic tyrosine-based motif C Xu, E Gagnon, ME Call, JR Schnell, CD Schwieters, CV Carman, ... Cell 135 (4), 702-713, 2008 | 530 | 2008 |
Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation A Peters, LA Pitcher, JM Sullivan, M Mitsdoerffer, SE Acton, B Franz, ... Immunity 35 (6), 986-996, 2011 | 523 | 2011 |
Shared Human T Cell Receptor Vβ Usage to Immunodominant Regions of Myelin Basic Protein KW Wucherpfennig, K Ota, N Endo, JG Seidman, A Rosenzweig, ... Science 248 (4958), 1016-1019, 1990 | 502 | 1990 |
Structure of a human insulin peptide–HLA-DQ8 complex and susceptibility to type 1 diabetes KH Lee, KW Wucherpfennig, DC Wiley Nature immunology 2 (6), 501-507, 2001 | 465 | 2001 |
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein KC O'Connor, KA McLaughlin, PL De Jager, T Chitnis, E Bettelli, C Xu, ... Nature medicine 13 (2), 211-217, 2007 | 444 | 2007 |
Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse K Choudhuri, J Llodrá, EW Roth, J Tsai, S Gordo, KW Wucherpfennig, ... Nature 507 (7490), 118-123, 2014 | 436 | 2014 |